Impact of ursodeoxycholic acid treatment on Fontan-associated liver disease
UDCA treatment significantly reduced liver enzyme levels, including GGT, and mitigated the progression of HCC. UDCA may be beneficial for patients with FALD.
Authors
- Kei Inai (ORCID: https://orcid.org/0000-0002-9995-778X)
- Yuri Ogasawara
- Katsutoshi Tokushige (ORCID: https://orcid.org/0000-0002-1004-7369)
- Yousuke Nakai (ORCID: https://orcid.org/0000-0001-7411-1385)
- Taniai Makiko
- Eriko Shimada (ORCID: https://orcid.org/0000-0002-9689-4031)
- Tomomi Kogiso (ORCID: https://orcid.org/0000-0003-1248-4324)
Institutions
- Japan Community Healthcare Organization (JP)
- Tokyo Women's Medical University (JP)
- Koto Hospital (JP)
Publication Details
- Journal
- Journal of Gastroenterology
- Published
- 2024-11-27
- DOI
- https://doi.org/10.1007/s00535-024-02168-x
- Citations
- 6
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 2.22
Funders
- National Center for Global Health and Medicine